News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Achieving the 90-90-90 target
UNAIDS outlines progress on HIV, but decries funding cuts

The Joint United Nations Programme on HIV/AIDS (UNAIDS) released its latest report on the status of the HIV epidemic and the global response ahead of the 10th International AIDS Society Conference on HIV

Published
22 July 2019
By
Liz Highleyman
Sexually transmitted infections tests and treatment
PrEP services could enhance STI control, says World Health Organization

The roll-out of pre-exposure prophylaxis (PrEP) provides an opportunity to bring down the incidence of sexually transmitted infections (STIs), provided that PrEP and STI programmes are better

Published
22 July 2019
By
Roger Pebody
Activism
‘TAC protected the man who sexually harassed me’

One of South Africa's most influential civil society organisations and its leaders may have flouted justice to protect a close ally, according to the woman who dared to speak up about her sexual harassment.

Published
21 July 2019
From
Health-e
Achieving the 90-90-90 target
UN Aids target to end epidemic by 2030 at risk as funding falls for first time

The pace of reducing new HIV infections is slowing and progress in accessing treatment is decreasing, putting UN targets to end the Aids epidemic by 2030 in doubt.

Published
21 July 2019
From
The Guardian
PrEP programmes and uptake
No new cases of HIV among people in Wales taking PrEP

Vaughan Gething, the Welsh minister for health and social services, said he was “delighted” that access to PrEP was now “fully embedded” into sexual health services.

Published
21 July 2019
From
The Pharmaceutical Journal
PrEP
Market for HIV Prevention Drugs May More Than Double, Citi Says

An experimental drug from Merck & Co may lead the way in the U.S. market, Citi said. Baum estimates MK-8591 may reach sales of $7 billion in HIV. Of that total, $3.5 billion may come from pre-exposure prophylaxis, or PrEP, as the preventative treatments are called.

Published
21 July 2019
From
Bloomberg
Women
The New Face of HIV and Treating the 'Hardly Reached'

Physicians, scientists, government agencies, and companies are questioning whether the way they've always recruited for clinical trials still serves patients.

Published
20 July 2019
From
Medscape (requires free registration)
The search for a cure
How can researchers reduce risks to sexual partners in studies involving treatment interruptions?

As studies working towards a functional cure or HIV eradication are creating risks not only for the HIV-positive people who take part, but also their sexual partners,

Published
20 July 2019
By
Roger Pebody
African migrants
Deportation fears, uncertainty over health insurance and stigma are barriers to accessing HIV services for undocumented African migrants in the US

Qualitative research carried out with undocumented African migrants in New York City revealed that fears of discovery and deportation presented a substantial barrier to seeking out HIV

Published
19 July 2019
By
Krishen Samuel
Young people
Less than half of adolescents with HIV since birth in the US have an undetectable viral load

Engagement with the HIV care continuum among individuals with perinatally-acquired HIV in the United States falls well below targets, research published in the online edition of the

Published
18 July 2019
By
Michael Carter
← First12345...740Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.